Cartilage Degeneration Market: By Treatment Modality, By Application, By Type of Treatment, By Site of Action, By End User, Geography

Cartilage Degeneration Market Size, Share, Growth, Trends, and Global Industry Analysis: By Treatment Modality (Cell-Based, Non-Cell-Based), By Application (Hyaline Cartilage, Fibrocartilage), By Type of Treatment (Palliative, Intrinsic Repair Stimulus), By Site of Action (Knee Cartilage Repair), By End User (Hospitals, Diagnostic centres, Orthopaedic Hospitals, Ambulatory surgical centres), Region

Cartilage Degeneration Market size was valued at US$ 13,926.2 million in 2023 and is poised to grow at a CAGR of 5.9% from 2024 to 2030. The global market provides a detailed overview and which can be segmented by treatment modality, application, type of treatment, site of action, end user, and region. By treatment modality, the market has been segmented into cell-based, and non-cell-based. By treatment modality, the cell-based segment held the largest revenue share of the market in past years and is expected to have the fastest growth rate over the forecasted period due rise in cartilage degeneration among various aged people which leads to enhances demand for cell-based cartilage treatment. By application, the market has been segmented into hyaline cartilage and fibrocartilage. By application, the fibrocartilage segment held the largest revenue share of the gastric cancer therapy market in past years and is expected to have the fastest growth rate over the forecasted period due to a high prescription rate. By type of treatment, the market has been segmented into palliative and intrinsic repair stimuli. By the site of action, the market has been segmented into knee cartilage repair. The knee segment accounted for the highest share of the market. The growth of this segment is attributed to the increasing prevalence of knee injuries.

For instance, according to a study published in an online newspaper, which is based on NCBI data, an estimated 1 in 4 adults suffer from chronic knee pain. Moreover, the prevalence of knee pain has witnessed a massive growth of around 40.0% during the past 4 decades. Furthermore, increasing awareness of the benefits provided by cartilage repair is also anticipated to drive the growth of the knee segment. Based on the end user, the segment has been segregated into hospitals, diagnostic centers, orthopedic hospitals, and ambulatory surgical centers. The ambulatory surgical clinic segment held the largest share of the market in 2019. Also, the segment is expected to register the highest CAGR in the market during the forecast period.

Cartilage Degeneration Market Key Developments

  • In Jan 2021, New Treatment Target was discovered that halts osteoarthritis-like knee cartilage degeneration.

Cartilage Degeneration Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.9%

Largest Market

North America

Fastest Growing Market

Asia pacific

Cartilage Degeneration Market Dynamics

Obesity has a substantial effect on the musculoskeletal system, resulting in the degeneration of bones, cartilage, and ligaments. Furthermore, the condition, along with other prominent factors, is strongly related to the increased risk of rapid cartilage loss. The increasing prevalence of obesity is anticipated to accelerate the incidence of cartilage degeneration, which will further drive market growth.

Cartilage Degeneration Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 13,926.2 million

Market CAGR

5.9%

By Treatment Modality

  • Cell-Based
  • Non-Cell-Based

By Application

  • Fibrocartilage
  • Hyaline Cartilage

By End User

  • Hospitals
  • Diagnostic centres
  • Orthopaedic Clinics
  • Ambulatory surgical centres

By Region

  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA

Key Features of the Report

  • The cartilage degeneration market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

Frequently Asked Questions

The Global cartilage degeneration market size was valued at US$ 13,926.2 million in 2023 and is poised to grow at a CAGR of 5.9% from 2024 to 2030.

North America dominated the market and held a significant market share, and would expand to dominate the global market by making huge investments in healthcare sectors.

Product launches and acquisitions are the two key strategies opted by the leading companies in the market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Cartilage Degeneration Market Introduction 
2.1.Global Cartilage Degeneration Market  - Taxonomy
2.2.Global Cartilage Degeneration Market  - Definitions
2.2.1.Treatment Modality
2.2.2.Application
2.2.3.End User
2.2.4.Region
3.Global Cartilage Degeneration Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Cartilage Degeneration Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Cartilage Degeneration Market  By Treatment Modality, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Cell-Based
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Non-Cell-Based
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Cartilage Degeneration Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Fibrocartilage
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Hyaline Cartilage
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Cartilage Degeneration Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Diagnostic centres
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Orthopaedic Clinics
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Ambulatory surgical centres
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Cartilage Degeneration Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Cartilage Degeneration Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Treatment Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Cell-Based
9.1.2.Non-Cell-Based
9.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Fibrocartilage
9.2.2.Hyaline Cartilage
9.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Diagnostic centres
9.3.3.Orthopaedic Clinics
9.3.4.Ambulatory surgical centres
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Cartilage Degeneration Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Treatment Modality Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Cell-Based
10.1.2.Non-Cell-Based
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Fibrocartilage
10.2.2.Hyaline Cartilage
10.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Diagnostic centres
10.3.3.Orthopaedic Clinics
10.3.4.Ambulatory surgical centres
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Cartilage Degeneration Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Treatment Modality Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Cell-Based
11.1.2.Non-Cell-Based
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Fibrocartilage
11.2.2.Hyaline Cartilage
11.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Diagnostic centres
11.3.3.Orthopaedic Clinics
11.3.4.Ambulatory surgical centres
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Cartilage Degeneration Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Treatment Modality Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Cell-Based
12.1.2.Non-Cell-Based
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Fibrocartilage
12.2.2.Hyaline Cartilage
12.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Diagnostic centres
12.3.3.Orthopaedic Clinics
12.3.4.Ambulatory surgical centres
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Cartilage Degeneration Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Treatment Modality Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Cell-Based
13.1.2.Non-Cell-Based
13.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Fibrocartilage
13.2.2.Hyaline Cartilage
13.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Diagnostic centres
13.3.3.Orthopaedic Clinics
13.3.4.Ambulatory surgical centres
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Zimmer Biomet Holdings, Inc. (U.S.)
14.2.2.Vericel Corporation (U.S.)
14.2.3.Smith & Nephew plc (U.K.)
14.2.4.Osiris Therapeutics, Inc. (U.S.)
14.2.5.Arthrex Inc. (U.S.).
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Zimmer Biomet Holdings, Inc. (U.S.)
  • Vericel Corporation (U.S.)
  • Smith & Nephew plc (U.K.)
  • Osiris Therapeutics, Inc. (U.S.)
  • Arthrex Inc. (U.S.).

Related Industry Reports